Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 1—January 2007

Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; ‡Johns Hopkins University, Baltimore, Maryland, USA;

Main Article

Table 3

Multivariable analysis of outcomes of patients with and without multidrug-resistant (MDR) Acinetobacter infections, Baltimore hospitals, 2003–2004*

Outcome evaluatedMDR Acinetobacter vs. susceptible† 
OR (95% CI)MDR Acinetobacter vs. uninfected† 
OR (95% CI)
Length of stay, d2.5 (1.2–5.2)2.5 (1.2–5.4)
Intensive care unit length of stay, d2.1 (1.0–4.3)4.2 (1.5–11.6)
Mortality rate (%)2.6 (0.3–26.1)6.6 (0.4–108.3)

*OR, odds ratio; CI, confidence interval.
†Models include modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.

Main Article

Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.